Abstract
Introduction A new respiratory virus, SARS-CoV-2, has emerged and spread worldwide since late 2019. This study aims at analyzing clinical presentation on admission and the determinants associated with direct admission or transfer to intensive care units (ICUs) in hospitalized COVID-19 patients.
Patients and Methods In this prospective hospital-based study, socio-demographic, clinical and biological characteristics, on admission, of adult COVID-19 hospitalized patients were prospectively collected and analyzed. The outcome was admission/transfer to intensive care units compared with total hospital stay in medical wards according to patient characteristics.
Results Of the 412 patients included, 325 were discharged and 87 died in hospital. Multivariable regression showed increasing odds of admission/transfer to ICUs with male gender (OR, 1.99 [95%CI, 1.07-3.73]), temperature (OR, 1.37 [95% CI, 1.01-1.88] per degree Celsius increase), abnormal lung auscultation on admission (OR, 2.62 [95% CI, 1.40-4.90]), elevated level of CRP (OR, 6.96 [95% CI, 1.45-33.35 for CRP>100mg/L vs CRP<10mg/L). Increased time was observed between symptom onset and hospital admission (OR, 4.82 [95% CI, 1.61-14.43] for time >10 days vs time <3 days) and monocytopenia (OR, 2.49 [95% CI, 1.29-4.82]). Monocytosis was associated with lower risk of admission/transfer to ICUs (OR, 0.25 [95% CI, 0.05-1.13]).
Conclusions Clinical and biological features on admission and time until admission were associated with admission to ICUs. Signs to predict worsening on admission could be partially associated with the time until admission. This finding reinforces the need for appropriate guidelines to manage COVID-19 patients in this time window.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04290780
Clinical Protocols
https://www.medrxiv.org/content/10.1101/2020.04.08.20057471v1
Funding Statement
The project was partially funded by REACTing (REsearch and ACTion targeting emerging infectious diseases)-INSERM, France.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). Favorable approval of the Ile-de-France V Ethics committee on March 08, 2020 : 2020- A00546-33 Written informed consent was obtained from all patients for being included in the study. Data were analyzed anonymously.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
On behalf of COVID-Outcomes-HCL Consortium Laurent Argaud, Frédéric Aubrun, Marc Bonnefoy, Maude Bouscambert-Duchamp, Roland Chapurlat, Dominique Chassard, Christian Chidiac, Michel Chuzeville, Cyrille Confavreux, Sébastien Couraud, Gilles Devouassoux, Isabelle Durieu, Michel Fessy, Sylvain Gaujard, Alexandre Gaymard, Arnaud Hot, Géraldine Martin Gaujard, Emmanuel Morelon, Vincent Piriou, Véronique Potinet, Jean-Christophe Richard, Thomas Rimmele, Pascal Sève, Alain Sigal, Karim Tazarourte.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.